Yale Cancer Center
at Smilow Cancer Hospital
Yale Cancer Center is Connecticut's only cancer center designated as a Comprehensive Cancer Center by the National Cancer Institute—and one of only 57 in the nation. The significance of this designation has profound implications for those who choose Smilow Cancer Hospital as the place where they will be cared for and receive treatment for their cancer. National Cancer Institute cancer centers are national leaders in cancer research, prevention, detection, and treatment. This provides patients at Smilow Cancer Hospital with novel treatment options and expert care.
News
Showing 3 of 267
Fact Sheets
Showing 4 of 318
News from Yale Cancer Center
Showing 3 of 1139
- Medscape (With Mitchell Clark, MD, MPH)
How Strong Is Antioxidants’ Link to Cervical Cancer Risk?
- People (With Maryam Lustberg, MD, MPH)
The Subtle Symptoms That Prompted These Women to Get a Breast Cancer Screening
- PEOPLE Online (with Maryam Lustberg, MD)
10 Ways to Advocate for Yourself After a Breast Cancer Diagnosis
Clinical Trials
Showing 2 of 318
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
- Lung Cancer
A Controlled Multi-Arm Ph1 Study Evaluating the Safety and Feasibility of TCR Engineered Donor TCells Targeting HA1 (TSC-100) or HA2 (TSC-101) in HLA-A0201 Positive Patients Undergoing Haploidentical Allogeneic Stem Cell Transplantation
- Leukemia & Hematologic Cancers